Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Smit, Andries J ^a   Smit, Jitske M ^b   Botterblom, Gijs J ^a   Mulder, Douwe J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b GELRE HOSPITALS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; AUTOFLUORESCENCE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DECISION TREE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIET RESTRICTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; FINNISH DIABETES RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN AUTOFLUORESCENCE; SKIN AUTOFLUORESCENCE BASED DECISION TREE;

ADULT; AGED; BLOOD GLUCOSE; DECISION TREES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; QUESTIONNAIRES; SKIN; SPECTROMETRY, FLUORESCENCE;

EID: 84878627651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065592     Document Type: Article

References (27)

1. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T, (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343: d7163 doi: 10.1136/bmj.d7163.
2. Von Eckardstein A, Schulte H, Assmann G, (2000) Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Journal of Clinical Endocrinology and Metabolism 85: 3101-3108.
3. Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K, (2004) Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 47: 1566-1573.
4. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes (2009) Diabetes Care. 32: 1327-1334.
5. American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes (2010) Endocr. Pract16: 155-156.
6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group N Engl J Med 346: 393-403.
7. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350.
8. Silventoinen K, Pankow J, Lindström J, Jousilahti P, Hu G, et al. (2005) The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil 12: 451-458.
9. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 164-171.
10. Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, et al. (2010) A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 42Suppl 1: S3-S36.
11. Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, (2010) Take action to prevent diabetes-the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 42Suppl 1: S37-s55.
12. Smit AJ, Gerrits EG, (2010) Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens 19: 527-33.
13. Meerwaldt R, Links TP, Graaff RG, Thorpe S, Baynes JW, et al. (2005) Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 1043: 290-298.
14. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR, (2008) Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359: 1565-1576.
15. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA, (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589.
16. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN, (2007) Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Diabetes Care 30: 1120-1124.
17. Mulder DJ, van Haelst PL, Graaff R, Gans ROB, Zijlstra F, et al. (2009) Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 17: 162-168.
18. Nienhuis HL, Westra J, Smit AJ, Limburg PC, Kallenberg CG, et al. (2009) AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity 42: 302-304.
19. Meerwaldt R, Graaff R, Huisman RJ, Links TP, Thorpe SR, et al. (2005) Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation endproducts, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16: 3687-3693.
20. Hische M, Luis-Dominguez O, Pfeiffer AF, Schwarz PE, Selbig J, et al. (2010) Decision trees as a simple-to-use and reliable tool to identify individuals with impaired glucose metabolism or type 2 diabetes mellitus. Eur J Endocrinol 163: 565-571.
21. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, et al. (2010) Reference values of skin autofluorescence. Diabetes Technol Ther 12: 399-403.
22. Koetsier M, Nur E, Chunmao H, Lutgers HL, Links TP, et al. (2010) Skin color independent assessment of aging using skin autofluorescence. Opt Express 18: 14416-14429.
23. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJG, et al. (2006) Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes Diabetes Care. 29: 2654-2659.
24. Lorenzo C, Williams K, Hunt KJ, Haffner SM, (2007) The National Cholesterol Education Program- Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30: 8-13.
25. Carson AP, Reynolds K, Fonseca VA, Huntner P, (2010) Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 33: 95-97.
26. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, et al. (2010) Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 33: 2184-2189.
27. Schwarz PE, Li J, Lindstrom J, Tuomilehto J, (2009) Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 41: 86-97.